Chronic Obstructive Pulmonary Disease
Conditions
Interventions
The experimental group:Yu Ping Feng Granule
Sponsors
The First Affiliated Hospital of Guangzhou Medical University
Eligibility
Sex/Gender
All
Age
40 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Subjects were diagnosed as having COPD that was defined by the GOLD(2013) criteria, and FEV1 (post bronchodilator) between 30% and 79% of predicted value; 2. Subjects maintaine clinically stable, and have no respiratory infections and COPD exacerbations within 4 weeks prior to baseline visit; 3. Subjects have a history of at least two documented COPD exacerbations or one hospitalization for COPD exacerbation within 1 year prior to baseline visit; 4. Age between 40 and 80 years; 5. Signed the informed consent.
Exclusion criteria
Exclusion criteria: Patient s had a history of: 1. physician-diagnosed asthma and non-COPD respiratory disorders; 2. lung volume reduction surgery or transplantation; 3. long-term oxygen therapy (12 h or more per day) required; 4. pulmonary rehabilitation; 5. alcohol or drug abuse; 6. allergic to the study medication; 7. current use of oral corticosteroids; 8. severe heart, liver, and kidney diseases; 9. Those in pregnancy or lactation; 10. patients wo is participating in other study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| numbers of exacerbations; | — |
Secondary
| Measure | Time frame |
|---|---|
| start and stop date of the exacerbation;AECOPD severity;FEV1;FVC;MMEF;PEF;CAT; | — |
Countries
China
Contacts
Public ContactZheng Jinping
Outcome results
None listed